Last reviewed · How we verify
Candidiasis of the esophagus
Approved treatments
- Cancidas · Merck & Co.
Cancidas works by inhibiting the synthesis of beta-1,6-glucan, a critical component of the fungal cell wall. - Eraxis · Vicuron Holdings
Eraxis works by inhibiting the synthesis of beta-1,3-D-glucan, a critical component of the fungal cell wall. - Mycamine · Teva Pharms Usa Inc
- Sporanox · Sebela Ireland Ltd
- Abelcet · Astellas Pharma
- Diflucan · Pfizer Inc.
- Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Candidiasis of the esophagus patent landscape — cliff calendar, originator estates, attackable patents
- Candidiasis of the esophagus treatment landscape brief
- Candidiasis of the esophagus treatment updates RSS
Frequently asked questions about Candidiasis of the esophagus
What drugs treat Candidiasis of the esophagus?
Tracked treatments include Cancidas, Eraxis, Mycamine, Sporanox, Abelcet, Diflucan, Fluconazol.
What is the treatment for Candidiasis of the esophagus?
Standard treatment for Candidiasis of the esophagus includes Cancidas, Eraxis, Mycamine, Sporanox, Abelcet. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Candidiasis of the esophagus patent cliff · Candidiasis of the esophagus CI report
- Treatment: Cancidas · Merck & Co.
- Treatment: Eraxis · Vicuron Holdings
- Treatment: Mycamine · Teva Pharms Usa Inc
- Treatment: Sporanox · Sebela Ireland Ltd
- Treatment: Abelcet · Astellas Pharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing